Efficacy and safety of lamivudine (3TC) in renal transplant patients with chronic hepatitis B.

被引：0
|
作者：
Antoine, C
Landau, A
Menoyo, V
Duong, JP
Duboust, A
Glotz, D
机构：
[1] Hop Broussais, Sce Nephrol, F-75674 Paris, France
[2] Hop Broussais, Sce Gastroenterol, F-75674 Paris, France
[3] Hop Broussais, Sce Anatomopathol, F-75674 Paris, France
[4] Inserm U430, Paris, France
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00865
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
841
引用
收藏
页码：S217 / S217
页数：1
相关论文
共 50 条
  • [41] Efficacy of extended lamivudine therapy after HBV DNA breakthrough in Korean patients with chronic hepatitis B.
    Park, YH
    Suh, DJ
    Lee, HC
    Chung, YH
    Lee, YS
    HEPATOLOGY, 2002, 36 (04) : 643A - 643A
  • [42] 3TC may help hepatitis patients
    不详
    AIDS PATIENT CARE AND STDS, 2000, 14 (01) : 63 - 63
  • [43] EFFICACY AND SAFETY OF LAMIVUDINE PLUS ADEFOVIR FOR UP TO 5 YEARS IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B
    Choi, A. Ra
    Ahn, Sang Hoon
    Kim, Do Young
    Kim, Seung Up
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    HEPATOLOGY, 2011, 54 : 1060A - 1060A
  • [44] Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance
    Song, Min-Ning
    Hong, Mei-Zhu
    Luo, Dan-Qing
    Huang, Wen-Qi
    Min, Feng
    Fan, Rong-Hua
    Wu, Wei-Bing
    Zhang, Li
    WORLD JOURNAL OF HEPATOLOGY, 2012, 4 (12) : 389 - 393
  • [45] Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance
    Min-Ning Song
    Mei-Zhu Hong
    Dan-Qing Luo
    Wen-Qi Huang
    Feng Min
    Rong-Hua Fan
    Wei-Bing Wu
    Li Zhang
    World Journal of Hepatology, 2012, (12) : 389 - 393
  • [46] 3TC effective against hepatitis B virus
    不详
    AIDS PATIENT CARE AND STDS, 1997, 11 (02) : 96 - 96
  • [47] Dose-finding and safety of lamivudine (LAM) in children and adolescents with chronic hepatitis B.
    Sokal, E
    Roberts, EA
    Mieli-Vergani, G
    McPhillips, P
    Johnson, M
    Boxall, E
    Kelly, D
    HEPATOLOGY, 1998, 28 (04) : 489A - 489A
  • [48] Uptake properties of lamivudine (3TC) by a continuous renal epithelial cell line
    Leung, S
    Bendayan, R
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2001, 79 (01) : 59 - 66
  • [49] Resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B.
    Osiowy, C
    Heathcote, J
    Zoulim, F
    Willems, B
    Villeneuve, JP
    HEPATOLOGY, 2005, 42 (04) : 586A - 587A
  • [50] Two years lamivudine therapy in patients with chronic hepatitis B. Analysis of efficacy and emergence of HBV genomic variations
    Buti, M
    Jardi, R
    Cotrina, M
    Rodriguez-Frias, E
    de Castro, EC
    Costa, X
    Esteban, R
    Guardia, J
    JOURNAL OF HEPATOLOGY, 2000, 32 : 111 - 111
12345